188 related articles for article (PubMed ID: 37374301)
41. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
42. Postmenopausal Hyperandrogenism Associated With Synchronous Ovarian Brenner Tumor, Bilateral Leydig Cell Tumor, and Adrenal Mass.
Salim M; Dasaraju S; Erickson B; Khalifa M; Burmeister LA
Cureus; 2024 Mar; 16(3):e55334. PubMed ID: 38559537
[TBL] [Abstract][Full Text] [Related]
43. Hyperandrogenism caused by ovarian Leydig cell tumour: finding the needle in a haystack.
Tong CV; Tai YT
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318251
[TBL] [Abstract][Full Text] [Related]
44. Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report.
Vatopoulou A; Gkrozou F; Birbas E; Kanavos T; Skentou C; Miliaras D
Case Rep Womens Health; 2023 Sep; 39():e00537. PubMed ID: 37692362
[TBL] [Abstract][Full Text] [Related]
45. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis.
Yetkin DO; Demirsoy ET; Kadioglu P
Gynecol Endocrinol; 2011 Apr; 27(4):237-40. PubMed ID: 20518640
[TBL] [Abstract][Full Text] [Related]
46. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
[TBL] [Abstract][Full Text] [Related]
47. [A case of postmenopausal hyperandrogenism caused by a lipid cell tumor].
Witek A; Skałba P; Chełmicki Z; Pajak J
Wiad Lek; 2002; 55(1-2):125-30. PubMed ID: 12043310
[TBL] [Abstract][Full Text] [Related]
48. Bilateral Leydig Cell Hyperplasia: A Rare Cause of Postmenopausal Hirsutism.
Pathmanathan S; De Silva SDN; Sumanatilleke M; Lokuhetty D; Ranathunga UVV
Case Rep Endocrinol; 2022; 2022():8804856. PubMed ID: 35190778
[TBL] [Abstract][Full Text] [Related]
49. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women.
Bahaeldein E; Brassill MJ
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153
[TBL] [Abstract][Full Text] [Related]
50. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
[TBL] [Abstract][Full Text] [Related]
51. Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman.
Marcondes JA; Curi DD; Matsuzaki CN; Barcellos CR; Rocha MP; Hayashida SA; Baracat EC
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1184-8. PubMed ID: 19082308
[TBL] [Abstract][Full Text] [Related]
52. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
53. [Leydig cell tumor as a cause of hirsutism in a postmenopausal woman].
Matuszczyk A; Petersenn S; Lahner H; Haude M; Veit P; Becker JU; Kimmig R; Bockisch A; Mann K
Med Klin (Munich); 2007 Mar; 102(3):259-62. PubMed ID: 17345023
[TBL] [Abstract][Full Text] [Related]
54. An unusual circulating steroid profile in a virilized postmenopausal woman.
Benavent Correro P; Sáenz Valls M; García Cano A; Jiménez Mendiguchia L; Moreno Moreno E; Luque-Ramírez M
Diagnosis (Berl); 2018 Jun; 5(2):83-87. PubMed ID: 29752879
[TBL] [Abstract][Full Text] [Related]
55. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
[TBL] [Abstract][Full Text] [Related]
56. Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case.
Loh KC; Lo JC; Zaloudek CJ; Fitzgerald PA
Ann Acad Med Singap; 1998 Sep; 27(5):712-6. PubMed ID: 9919347
[TBL] [Abstract][Full Text] [Related]
57. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
Dunne C; Havelock JC
J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
[TBL] [Abstract][Full Text] [Related]
58. Alopecia and hirsutism in a postmenopausal woman as the presenting complaint of ovarian hilus (Leydig) cell tumor.
Berbegal L; Albares MP; De-Leon FJ; Negueruela G
Actas Dermosifiliogr; 2015 Oct; 106(8):676-8. PubMed ID: 25910403
[No Abstract] [Full Text] [Related]
59. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin.
Vollaard ES; van Beek AP; Verburg FA; Roos A; Land JA
J Clin Endocrinol Metab; 2011 May; 96(5):1197-201. PubMed ID: 21307133
[TBL] [Abstract][Full Text] [Related]
60. A Case of Ovarian Hyperthecosis in a Postmenopausal Woman.
Yousaf S; Nizar R; John L; Simpson A
JCEM Case Rep; 2023 Nov; 1(6):luad148. PubMed ID: 38077307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]